Related Experiment Video
Updated: Sep 25, 2025
07:13
Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts
Published on: May 13, 2014
13.5K
Arctiin elevates osteogenic differentiation of MC3T3-E1 cells by modulating cyclin D1
1Department of Joint Surgery and Sports Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
Bioengineered
|April 27, 2022
Summary
Arctiin, derived from Arctium lappa, promotes osteoblast differentiation by upregulating cyclin D1 (Ccnd1). This suggests Arctiin
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Osteoporosis is a bone metabolism disorder.
- Arctiin is a lignin isolated from Arctium lappa.
- Understanding Arctiin's effects on osteoblasts is crucial for osteoporosis research.
Purpose of the Study:
- Investigate Arctiin's impact on MC3T3-E1 osteoblast differentiation.
- Elucidate the mechanisms underlying Arctiin's effects.
- Assess Arctiin's potential as a therapeutic agent for osteoporosis.
Main Methods:
- MC3T3-E1 cells were treated with varying concentrations of Arctiin.
- Gene and protein expression of osteogenesis markers were analyzed using RT-qPCR and Western blotting.
- Alkaline phosphatase (ALP) activity and calcium nodule formation were quantified.
- The role of cyclin D1 (Ccnd1) was investigated through gene silencing.
Main Results:
- Arctiin dose-dependently increased expression of RUNX2, COL1A1, OCN, and OPN.
- Elevated ALP activity and calcium deposition were observed.
- Arctiin significantly enhanced Ccnd1 expression.
- Ccnd1 knockdown reversed Arctiin's pro-osteogenic effects.
Conclusions:
- Arctiin promotes MC3T3-E1 osteoblast differentiation.
- This effect is mediated through the upregulation of Ccnd1.
- Arctiin shows potential as a therapeutic target for osteoporosis.
